|
Volumn 18, Issue 4, 2005, Pages 749-751
|
RSV 2005: Global impact, changing concepts, and new challenges
|
Author keywords
[No Author keywords available]
|
Indexed keywords
A 60444;
ALPHA INTERFERON;
ANTIVIRUS AGENT;
INTERLEUKIN 10;
INTERLEUKIN 13;
INTERLEUKIN 4;
INTERLEUKIN 8;
INTERLEUKIN 9;
LEUKOTRIENE C4;
LIVE VACCINE;
MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA;
RANTES;
SMALL INTERFERING RNA;
UNCLASSIFIED DRUG;
ANTIGEN PRESENTING CELL;
BRONCHIOLITIS;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CELLULAR IMMUNITY;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CONFERENCE PAPER;
CYTOKINE PRODUCTION;
DISEASE SEVERITY;
GENE EXPRESSION REGULATION;
HAPLOTYPE;
HUMAN;
IMMUNE RESPONSE;
IMMUNE SYSTEM;
IMMUNOPATHOGENESIS;
INTERFERON PRODUCTION;
NONHUMAN;
RESPIRATORY SYNCYTIAL PNEUMOVIRUS;
TRANSCRIPTION REGULATION;
VIRUS TITRATION;
AGED;
ANTIVIRAL AGENTS;
HUMANS;
INFANT;
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;
RESPIRATORY SYNCYTIAL VIRUS VACCINES;
RESPIRATORY SYNCYTIAL VIRUSES;
RESPIRATORY SYNCYTIAL VIRUS;
RICE STRIPE VIRUS;
|
EID: 29844449778
PISSN: 08828245
EISSN: None
Source Type: Journal
DOI: 10.1089/vim.2005.18.749 Document Type: Conference Paper |
Times cited : (7)
|
References (0)
|